Literature DB >> 8943710

Autologous anti-idiotypic antibody response is regulated by the level of circulating complementary idiotype.

C Borghesi1, C Nicoletti.   

Abstract

BALB/c mice injected with lyophilized vaccine from Streptococcus pneumoniae R36a (Pn) predominantly responded with antibody molecules the vast majority of which expressed the public idiotype T15 and were directed to the immunodominant epitope phosphorylcholine (PC). However, after a single immunization with Pn vaccine young (3-month-old) BALB/c mice did not produce any specific anti-T15 antibody response. In contrast, young D1.LP mice were able to mount a specific anti-T15 response upon primary immunization with pneumococcal vaccine. The anti-PC response in the two mouse strains differed in that the proportion of antibody molecules that expressed the T15 idiotype for Pn-primed D1.LP mice showed a smaller proportion of PC-specific antibody expressing the T15 idiotype. Neonatal injection of anti-T15 monoclonal antibodies led to a long-term suppression of the PC-specific T15+ B-cell clones but at young/adult age these mice maintained the ability to produce a normal amount of PC-specific antibody. Interestingly, the idiotypically-suppressed BALB/c mice mounted a significant anti-T15 response during the primary response to Pn. We interpreted these data as showing that the level of circulating idiotype may regulate the production of the complementary anti-idiotypic antibody. In addition, in vitro experiments demonstrated that the lack of the anti-T15 response during primary antibody response in BALB/c mice is probably because of a state of tolerance that is regulated by T cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943710      PMCID: PMC1456490          DOI: 10.1046/j.1365-2567.1996.d01-724.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Detection of anti-idiotype reactive cells in the response to phosphorylcholine.

Authors:  H Cosenza
Journal:  Eur J Immunol       Date:  1976-02       Impact factor: 5.532

2.  Analysis of T15 idiotopes by monoclonal antibodies: variability of idiotopic expression on phosphorylcholine-specific lymphocytes from individual inbred mice.

Authors:  J Cerny; R Wallich; G J Hammerling
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

3.  Production of auto-anti-idiotypic antibody during the normal immune response: changes in the auto-anti-idiotypic antibody response and the idiotype repertoire associated with aging.

Authors:  E A Goidl; G J Thorbecke; M E Weksler; G W Siskind
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

4.  Loss of immune competence with age may be due to auto-anti-idiotypic antibody regulation.

Authors:  M R Szewczuk; R J Campbell
Journal:  Nature       Date:  1980-07-10       Impact factor: 49.962

5.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

6.  Specific suppression of the antibody response in vitro by serum from paralyzed mice.

Authors:  P B Brown; H Köhler; D A Rowley
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

7.  A study of autologous anti-idiotypic antibody-forming cells in mice of different ages and genetic backgrounds.

Authors:  C Nicoletti; J Cerny
Journal:  Cell Immunol       Date:  1992-10-15       Impact factor: 4.868

8.  Expression of new idiotypes following neonatal idiotypic suppression of a dominant clone.

Authors:  A Augustin; H Cosenza
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

9.  Genetics of a new IgVH (T15 idiotype) marker in the mouse regulating natural antibody to phosphorylcholine.

Authors:  R Lieberman; M Potter; E B Mushinski; W Humphrey; S Rudikoff
Journal:  J Exp Med       Date:  1974-04-01       Impact factor: 14.307

10.  Production of auto-anti-idiotypic antibody during the normal immune response to TNP-ficoll. III. Absence in nu/nu mice: evidence for T-cell dependence of the anti-idiotypic-antibody response.

Authors:  A F Schrater; E A Goidl; G J Thorbecke; G W Siskind
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

View more
  6 in total

1.  Low doses of IgG from atopic individuals can modulate in vitro IFN-γ production by human intra-thymic TCD4 and TCD8 cells: An IVIg comparative approach.

Authors:  Fábio da Ressureição Sgnotto; Marília Garcia de Oliveira; Aline Aparecida de Lima Lira; Luciana Bento-de-Souza; Alberto José da Silva Duarte; Jefferson Russo Victor
Journal:  Hum Vaccin Immunother       Date:  2017-04-25       Impact factor: 3.452

2.  IgG from Adult Atopic Dermatitis (AD) Patients Induces Nonatopic Neonatal Thymic Gamma-Delta T Cells (γδT) to Acquire IL-22/IL-17 Secretion Profile with Skin-Homing Properties and Epigenetic Implications Mediated by miRNA.

Authors:  Beatriz Oliveira Fagundes; Thamires Rodrigues de Sousa; Andrezza Nascimento; Lorena Abreu Fernandes; Fábio da Ressureição Sgnotto; Raquel Leão Orfali; Valéria Aoki; Alberto José da Silva Duarte; Sabri Saeed Sanabani; Jefferson Russo Victor
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

3.  Maternal immunization with ovalbumin prevents neonatal allergy development and up-regulates inhibitory receptor Fc gamma RIIB expression on B cells.

Authors:  Jefferson R Victor; Bruno P Muniz; Ana E Fusaro; Cyro A de Brito; Eliana F Taniguchi; Alberto J S Duarte; Maria N Sato
Journal:  BMC Immunol       Date:  2010-03-11       Impact factor: 3.615

Review 4.  Nutritionally mediated programming of the developing immune system.

Authors:  Amanda C Palmer
Journal:  Adv Nutr       Date:  2011-09-06       Impact factor: 8.701

Review 5.  Allergen-specific IgG as a mediator of allergy inhibition: Lessons from mother to child.

Authors:  Jefferson Russo Victor
Journal:  Hum Vaccin Immunother       Date:  2016-11-03       Impact factor: 3.452

6.  Neonatal idiotypic exposure alters subsequent cytokine, pathology, and survival patterns in experimental Schistosoma mansoni infections.

Authors:  M A Montesano; D G Colley; S Eloi-Santos; G L Freeman; W E Secor
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.